Carious lesion with a pseudo-intact enamel surface layer
The Monomer-Peptide 104 technology diffuses until the depth of the carious lesion within 5 minutes
The peptides of the Monomer-Peptide104 technology assemble into a biomatrix within the carious lesion
The biomatrix formed by the Monomer-Peptide104 technology attracts calcium and phosphate ions from the saliva for de novo nucleation of hydroxyapatite crystals, leading to remineralization
After 6 months, 80% of caries treated with CR+FV became inactive as opposed to only 34% of those treated with FV alone, as assessed by Nyvad Caries Activity Criteria.
Greater decrease in laser fluorescence readings (assessed using DIAGNODent), signifying greater caries regression for treatment with CR+FV compared to FV alone.